Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 19, 2025
Language impairment is associated with faster progression in progressive supranuclear palsy-Richardson syndromeIndira Garcia-Cordero, Juan Camilo Vargas-Gonzalez, Mohsen Hadian, et al.
The Lancet. Neurology|May 25, 2019
Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trialAdam L Boxer, Irfan Qureshi, Michael Ahlijanian, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 29, 2021
A Modified Progressive Supranuclear Palsy Rating ScaleMarie-Therese Grötsch, Gesine Respondek, Carlo Colosimo, et al.
Movement Disorders Clinical Practice|January 10, 2026
Voice and Speech in Atypical Parkinsonian DisordersFederico Rodriguez-Porcel, Farwa Ali, Michiko Bruno, et al.
American Journal of Human Genetics|March 16, 2007
Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphismsStacey Melquist, David W Craig, Matthew J Huentelman, et al.
The Lancet. Neurology|May 31, 2014
Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trialAdam L Boxer, Anthony E Lang, Murray Grossman, et al.
American Journal of Human Genetics|March 29, 2002
PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD studyAnita L DeStefano, Mark F Lew, Lawrence I Golbe, et al.
Archives of Neurology|June 14, 2006
Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD studyMei Sun, Jeanne C Latourelle, G Frederick Wooten, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 19, 2019
How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsyMax-Joseph Grimm, Gesine Respondek, Maria Stamelou, et al.
Frontiers in Neurology|July 19, 2021
Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of CareBrent Bluett, Alexander Y Pantelyat, Irene Litvan, et al.
Pageof 5